- Home
- TXG vs TIC Comparison
TXG vs TIC Comparison
Compare TXG & TIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- TIC
- Stock Information
- Founded
- TXG 2012
- TIC 1991
- Country
- TXG United States
- TIC United States
- Employees
- TXG N/A
- TIC N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- TIC
- Sector
- TXG Industrials
- TIC
- Exchange
- TXG Nasdaq
- TIC Nasdaq
- Market Cap
- TXG 1.0B
- TIC 1.5B
- IPO Year
- TXG 2019
- TIC N/A
- Fundamental
- Price
- TXG $8.63
- TIC $10.38
- Analyst Decision
- TXG Buy
- TIC Hold
- Analyst Count
- TXG 15
- TIC 1
- Target Price
- TXG $18.85
- TIC $13.00
- AVG Volume (30 Days)
- TXG 3.9M
- TIC 200.1K
- Earning Date
- TXG 05-08-2025
- TIC 05-27-2025
- Dividend Yield
- TXG N/A
- TIC N/A
- EPS Growth
- TXG N/A
- TIC N/A
- EPS
- TXG N/A
- TIC N/A
- Revenue
- TXG $610,785,000.00
- TIC $1,097,393,000.00
- Revenue This Year
- TXG $0.71
- TIC $4.52
- Revenue Next Year
- TXG $9.28
- TIC $5.23
- P/E Ratio
- TXG N/A
- TIC N/A
- Revenue Growth
- TXG N/A
- TIC 4.51
- 52 Week Low
- TXG $6.78
- TIC $8.76
- 52 Week High
- TXG $28.25
- TIC $14.28
- Technical
- Relative Strength Index (RSI)
- TXG 51.19
- TIC N/A
- Support Level
- TXG $7.72
- TIC N/A
- Resistance Level
- TXG $8.63
- TIC N/A
- Average True Range (ATR)
- TXG 0.43
- TIC 0.00
- MACD
- TXG 0.14
- TIC 0.00
- Stochastic Oscillator
- TXG 84.92
- TIC 0.00
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).